approval
saveIRBESARTAN — FDA approval
community read0 votes
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalIRBESARTAN — FDA approvalNov 25, 2025 · 316d ago
- approvalIRBESARTAN — FDA approvalNov 12, 2025 · 329d ago
- approvalIRBESARTAN — FDA approvalNov 4, 2025 · 337d ago
- approvalIRBESARTAN — FDA approvalOct 1, 2025 · 371d ago
- approvalIRBESARTAN — FDA approvalSep 30, 2025 · 372d ago
- approvalIRBESARTAN — FDA approvalNov 1, 2022 · 1436d ago
- approvalIRBESARTAN — FDA approvalFeb 28, 2022 · 1682d ago
- approvalIRBESARTAN — FDA approvalDec 8, 2021 · 1764d ago
same company · ±60 days · 6
- approvaltopiramate ER: TOPIRAMATE — FDA approvalJan 10, 2022
- approvaltopiramate ER: TOPIRAMATE — FDA approvalJan 10, 2022
- approvaltopiramate ER: TOPIRAMATE — FDA approvalJan 10, 2022
- approvaltopiramate ER: TOPIRAMATE — FDA approvalJan 10, 2022
- approvaltopiramate ER: TOPIRAMATE — FDA approvalJan 10, 2022
- approvaltopiramate ER: TOPIRAMATE — FDA approvalJan 10, 2022
🐶 often sniffed alongside
top 8- tagApproval214 co-mentions · 107 sources
- drugALDACTAZIDE152 co-mentions · 76 sources
- tagSmall Molecule107 co-mentions · 107 sources
- drugIRBESARTAN AND HYDROCHLOROTHIAZIDE76 co-mentions · 76 sources
- companyAurobindo Pharma Ltd20 co-mentions · 20 sources
- companyLupin Ltd10 co-mentions · 10 sources
- companyHetero Labs Ltd7 co-mentions · 7 sources
- companyJubilant Generics Ltd5 co-mentions · 5 sources
comments(0)
5-min edit window · permanent after that